Transforming Growth Factor-β1 in Cancer Immunology: Opportunities for Immunotherapy
Author:
Publisher
Springer Nature Switzerland
Link
https://link.springer.com/content/pdf/10.1007/978-3-031-26163-3_17
Reference143 articles.
1. Trikha P (2014 Aug) Carson WE 3rd. Signaling pathways involved in MDSC regulation. Biochim Biophys Acta 1846(1):55–65. https://doi.org/10.1016/j.bbcan.2014.04.003. Epub 2014 Apr 13. PMID: 24727385; PMCID: PMC4140957
2. Batlle E, Massagué J (2019) Transforming growth factor-β signaling in immunity and cancer. Immunity 50(4):924–940. https://doi.org/10.1016/j.immuni.2019.03.024.PMID:30995507;PMCID:PMC7507121
3. Derynck R, Turley SJ, Akhurst RJ (2021 Jan) TGFβ biology in cancer progression and immunotherapy. Nat Rev Clin Oncol 18(1):9–34. https://doi.org/10.1038/s41571-020-0403-1. Epub 2020 Jul 24. PMID: 32710082Zhai
4. Zhao H, Wei J, Sun J (2020 Dec) Roles of TGF-β signaling pathway in tumor microenvironment and cancer therapy. Int Immunopharmacol 89(Pt B):107101. https://doi.org/10.1016/j.intimp.2020.107101. Epub 2020 Oct 21. PMID: 33099067
5. Xue VW, Chung JY, Córdoba CAG, Cheung AH, Kang W, Lam EW, Leung KT, To KF, Lan HY, Tang PM (2020) Transforming growth factor-β: a multifunctional regulator of cancer immunity. Cancers (Basel) 12(11):3099. https://doi.org/10.3390/cancers12113099.PMID:33114183;PMCID:PMC7690808
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Overexpression of microRNA-611 inhibits TGF-β-induced epithelial-mesenchymal transition and migration in lung cancer cells through MAPKAP1;Cellular Signalling;2024-11
2. ANGPTL2: Is it a Novel Therapeutic Target Related to Tumor-Associated Macrophages in Esophageal Cancer?;Annals of Surgical Oncology;2024-09-06
3. miR‐542‐5p targets GREM1 to affect the progression of renal fibrosis;Journal of Biochemical and Molecular Toxicology;2024-08-24
4. A mathematical model for pancreatic cancer during intraepithelial neoplasia;2024-03-17
5. Tumor specific TGF-β insensitive CD8 + T cells augments the antitumor effect through inhibition of epithelial-mesenchymal transition in CD 105 + renal carcinoma stem cells;2024-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3